Cargando…
Omalizumab in Severe Refractory Vernal Keratoconjunctivitis in Children: Case Series and Review of the Literature
INTRODUCTION: Vernal keratoconjunctivis (VKC) is a severe form of pediatric ocular allergy, characterized by acute and chronic corneoconjunctival inflammation that may lead to visual sequelae. Although topical immunosuppressive drugs such as cyclosporine are usually effective, some severe forms may...
Autores principales: | Doan, Serge, Amat, Flore, Gabison, Eric, Saf, Sarah, Cochereau, Isabelle, Just, Jocelyne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5449293/ https://www.ncbi.nlm.nih.gov/pubmed/27909980 http://dx.doi.org/10.1007/s40123-016-0074-2 |
Ejemplares similares
-
Vernal keratoconjunctivitis: Current immunological and clinical evidence and the potential role of omalizumab
por: Doan, Serge, et al.
Publicado: (2023) -
Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis
por: Ang, Marcus, et al.
Publicado: (2012) -
Oral cyclosporine therapy for refractory severe vernal keratoconjunctivitis
por: Gokhale, Nikhil S, et al.
Publicado: (2012) -
Vernal keratoconjunctivitis
por: Addis, Hampton, et al.
Publicado: (2018) -
Pretreatment by omalizumab allows allergen-specific immunotherapy in children and young adult with severe allergic asthma
por: Lambert, Nathalie, et al.
Publicado: (2015)